Despite the significant increases of CSF clusterin and APL1β28 in AD and MCI patients, the average levels of [APL1β28]plasma and [clusterin]plasma were not different in the aMCI subjects compared to those in the healthy controls, a result that is consistent with a previous study by Thambisetty et al.73. Here, CLU is linked to Alzheimer disease.